Trial · NCT05716607
Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
NCT05716607, Not applicable, Withdrawn, Vastra Gotaland Region
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment Study in Patients Treated With Both Insulin & Hydrocortisone. Trials, record NCT05716607. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05716607
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
- NCT number
- NCT05716607
- Status
- Withdrawn
- Phases
- Not applicable
- Enrollment
- 0 participants, actual
- Lead sponsor
- Vastra Gotaland Region
- Conditions
- Diabetes Mellitus, Adrenal Insufficiency, Polyglandular Autoimmune Syndrome
- Interventions
- OD dual-release Hydrocortisone, TID Hydrocortisone
- First posted
- 2023-02-08
- Last updated
- 2026-07-07
Source ClinicalTrials.gov
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | glycemic variability | 4 weeks | glycemic variability |
| Secondary | HbA1c | 4 weeks | HbA1c |
| Secondary | Time in range (glucose) | 4 weeks | Time in range (glucose) |
| Secondary | Time above range (glucose) | 4 weeks | Time above range (glucose) |
| Secondary | Time below range (glucose) | 4 weeks | Time below range (glucose) |
| Secondary | Cortisol exposure-time profile | 4 weeks | Cortisol exposure-time profile |
| Secondary | systolic blood pressure | 4 weeks | systolic blood pressure in sitting position |
| Secondary | diastolic blood pressure | 4 weeks | diastolic blood pressure in sitting position |
| Secondary | ADDIQoL | 4 weeks | questionnaire: the Addison-specific quality-of-life (ADDIQoL) The AddiQoL is a 36-item questionnaire; each item contains six scoring categories. Twenty-five items are negative Health-Related Quality of Life (HRQoL) statements that need to be reversed for questionnaire scoring; thus, a higher score indicates a higher level of HRQoL. |
| Secondary | PGWB | 4 weeks | questionnaire: the Psychological General Well-Being (PGWB) index The Psychological General Well-Being Index (PGWBI) is a measure of the level of subjective psychological well-being. In detail, it assesses self-representations of intrapersonal affective or emotional states reflecting a sense of subjective well-being or distress and thus captures what we could call a subjective perception of well-being. Consisting of 22 standardized items (6 items for the short form), the tool produces a single measure of psychological well-being. The full measure also provides sub-scales to assess the following domains: anxiety, depression, positive well-being, self-control, general health, and vitality. |
1 to 10 of 23Source ClinicalTrials.gov
See all 23 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05716607
GET https://conductscience.org/api/trials/v1/NCT05716607/registered?page=2